EU medicines agencies reflect on lessons learned from COVID-19
The European Medicines Regulatory Network (EMRN) has been at the forefront of the fight against COVID-19 with its crucial role in the evaluation and monitoring of medicines, including vaccines. A joint report issued by the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) reviews the Network’s response and highlights the main learnings for any future health crises.
More information on the EMA Website.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (31 mai 2024). EU medicines agencies reflect on lessons learned from COVID-19. ELSIBI. Consulté le 9 décembre 2024 à l’adresse https://doi.org/10.58079/11r2d
